Developer docs
API playgroundTry for free, no card

Search company profiles

Azra AI

Full company profile

uuid0000gab

Namestring
Azra AI
Legal namestring
Azra AI
Websiteurl
azra-ai.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Azra AI is a Nashville, Tennessee-based healthcare AI company founded in 2022 that sells an enterprise platform automating clinical workflows across oncology, radiology, cardiology, emergency medicine, and clinical research. The platform is delivered through multiple modules — including oncology navigation (Journey), radiology incidental findings, high-risk screening, multi-disciplinary case review, tumor board, cancer registry abstraction, cardiology, ED discharge coordination, and enterprise analytics — and integrates with Epic and Cerner via HL7/FHIR. Underlying capabilities combine NLP for unstructured clinical text, predictive analytics, agentic AI with human-in-the-loop design, and process automation, with a reported sub-2% false positive rate on radiology incidental findings and a corpus of more than half a billion clinical reports processed annually across the deployed base. In May 2026 the company launched an Agentic AI Clinical Research Platform connecting health systems with pharma sponsors, and in April 2026 it acquired Thynk Health, adding lung cancer screening and oncology workflow capabilities and installing Daniel Weeks as COO.

The company monetizes through enterprise SaaS subscriptions, quote-based multi-year contracts with U.S. health systems, and managed clinical services that embed navigators, tumor board coordinators, and registry staff alongside the software. It has also introduced a pharma-sponsor transaction-based revenue stream via the Clinical Research Network. Customer disclosures indicate deployment at hundreds of U.S. health systems, including 5 of the top 10, but no individual customer logos or revenue concentration data are publicly disclosed. The company has raised approximately $15.9M across a 2022 seed round and a July 2025 Series 2 led by Connexa Capital with NewHealth Ventures and SJF Ventures.

Short descriptiontext

Azra AI is a Nashville-based healthcare AI company that sells an enterprise platform automating oncology, radiology, cardiology, ED, and clinical research workflows for U.S. health systems, integrating with Epic and Cerner.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology workflow automation, clinical AI platform, EHR integration software, cancer screening solutions, patient navigation software
Industry4 codes
PRIMARYHLACABAC
Enterprise Integration Engines & Interface Management (HL7 v2/X12/API)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code2 codes
  • Software Publishers5132
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Healthcare AI Workflow Automation
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Enterprise SaaS platform subscriptions
TypeSubscription Recurring
Description

Recurring enterprise contracts with U.S. health systems for the Azra AI platform spanning oncology, radiology, cardiology, ED continuity, clinical trials and registry automation. Deployed across hundreds of hospitals including five of the top ten U.S. healthcare systems, indicating large multi-year, enterprise SaaS agreements rather than transactional or self-serve pricing.

azra-ai.com
2Embedded clinical professional services (Navigation, MDM/Tumor Board, Cancer Registry Case Finding, Strategic Execution)
TypeManaged Services
Description

Azra-employed navigators, tumor board coordinators, registry case finders and clinical excellence teams are deployed as an extension of the customer's team, billed as managed services on top of the platform. Described as flexible capacity extension without long-term FTE commitments from the customer.

azra-ai.com
3Pharmaceutical / clinical research network partnerships
TypeTransaction Fee
Description

The Azra Clinical Research Network connects health systems to a pipeline of pharmaceutical studies, offering pharma companies a high-fidelity, "ready-to-enroll" site network. Represents a transaction- or sponsor-driven revenue stream from pharma for trial enrollment, feasibility and reporting services.

azra-ai.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Quote-based enterprise contract for the Azra AI platform and embedded services
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is not publicly disclosed. Customers engage via a demo / enterprise review; pricing model and billing cadence are negotiated per health system. No free trial, freemium tier, or self-serve sign-up is offered.

azra-ai.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Journey
Description

Azra AI's oncology navigation software product that surfaces cancer patients at diagnosis, delivers risk-stratified navigator worklists, automated workflows, and real-time analytics.

azra-ai.com
Core offering1 text field

Azra AI provides an agentic AI clinical intelligence platform that bi-directionally integrates with leading EHRs (Epic, Cerner) via HL7/FHIR to deliver closed-loop, enterprise patient management across oncology, radiology, cardiology, emergency department, cancer registry and clinical trial workflows. The platform applies clinically trained NLP and disease-specific classification models to unstructured pathology, radiology and clinical reports to extract findings, stratify risk, and route patients into structured care pathways. It is sold as multi-year enterprise SaaS subscriptions bundled with embedded Azra-employed clinical navigators, tumor board coordinators and registry case finders.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 3× faster to treatment vs. standard unmanaged follow-up
+7 more records
Product overview1 text field

Azra AI is offered as a single unified enterprise platform with a suite of integrated solution modules rather than standalone products. The core is the Azra AI Enterprise Platform — a healthcare-grade agentic AI and workflow automation layer that bi-directionally integrates with leading EHRs (Epic, Cerner) via HL7/FHIR to overlay closed-loop patient management onto existing systems. The platform comprises the Closed-Loop Patient Management backbone plus named modules: Journey (Oncology Navigation), Radiology Incidental Findings (lung, breast, pancreas, liver, renal, GYN, neuro), High-Risk Screening Follow-Up, Multi-Disciplinary Case Review, Tumor Board, Cancer Registry Automation, Cardiology (Structural Heart), ED Discharge Coordination, the Agentic AI Clinical Research Platform (introduced May 2026 with the Unified Patient Intelligence Layer and Azra Clinical Research Network), and Enterprise Analytics & Insights. Thynk Health, acquired in April 2026, extends the platform with lung cancer screening and incidental findings depth. Clinical Advisory Services (Strategic Execution, Navigation as a Service, MDM Tumor Board Coordination, Cancer Registry Case Finding) provide human-in-the-loop stewardship on top of the technology. Together these modules power solutions across lung and breast cancer screening, incidental findings, multi-disciplinary meetings, oncology care coordination, clinical trial matching, ED discharge, and reporting & analytics within a single coordinated ecosystem.

Product and service14 records
1Azra AI Enterprise Platform
CategoryCore Platform
Description

Healthcare enterprise AI platform that operationalizes underutilized clinical data to optimize and orchestrate care and clinical trial pathways. Combines agentic AI, multimodal data integration and workflow automation to transform fragmented clinical data into actionable intelligence, overlaying EHRs with bidirectional HL7/FHIR integration.

2Journey (Oncology Navigation)
CategoryOncology Solution
Description

Oncology navigation module that surfaces high-risk patients at the moment of cancer diagnosis, prioritizes worklists by acuity and distress risk, automates distress screenings, consult scheduling, and follow-up documentation, and feeds data back to the EHR.

3Agentic AI Clinical Research Platform
CategoryClinical Trials Solution
Description

Clinical research platform built on Azra AI's real-time care orchestration engine that introduces a Unified Patient Intelligence Layer, Conversational UI for feasibility, autonomous agentic pre-screening and enrollment, proactive trajectory tracking, the Azra Clinical Research Network, automated portfolio reporting, and full traceability to source EMR data.

4Radiology Incidental Findings
CategoryRadiology Solution
Description

AI-powered imaging solution that ingests HL7/FHIR radiology reports, uses NLP to extract incidental findings (location, size, density, margins, nodule count) with under 2% false positives, applies risk stratification, and routes patients into surveillance or treatment pathways using guideline-aligned models (Lung-RADS, Fleischner, BI-RADS, LI-RADS, Bosniak, ACG/AGA).

5High-Risk Screening Follow-Up
CategoryScreening Solution
Description

Screening follow-up and compliance solution covering Lung-RADS result tracking, BI-RADS surveillance interval management, and colorectal polyp surveillance that monitors every screening result, triggers guideline-matched follow-up activities, populates navigator worklists, and writes back to discrete EHR fields.

6Multi-Disciplinary Case Review
CategoryOncology Solution
Description

Module that continuously monitors patient populations, flags individuals with high-risk findings (lung nodules, suspicious masses, incidental findings), assembles customizable meeting agendas, captures recommendations during case conferences, assigns action items with due dates and ownership, and surfaces overdue actions via automated alerts.

7Tumor Board
CategoryOncology Solution
Description

Tumor board solution that proactively identifies newly diagnosed cancer patients, prepares customized case agendas with radiology, pathology and clinical history, captures recommendations, assigns navigation tasks, and supports Commission on Cancer (CoC) Standard 2.5 accreditation through structured data capture and automated reporting.

8Cancer Registry Automation
CategoryRegistry Solution
Description

Automated cancer registry case-finding solution that surfaces newly diagnosed cases by disease site in real time from pathology and radiology reports, integrates with the registry database, supports human-in-the-loop validation, and provides reporting for CoC, NAPBC, NAPRC, and NAACCR accreditation requirements.

9Cardiology (Structural Heart)
CategoryCardiology Solution
Description

AI-powered cardiology module for detection, acuity stratification, and closed-loop care coordination for structural heart disease (aortic and mitral stenosis). Surfaces findings from echocardiography, CT, and MRI, classifies by severity (mild/moderate/severe), routes to accountable care teams, and is expanding to automated population of STS/TVT registry fields.

10ED Discharge Coordination
CategoryEmergency Medicine Solution
Description

Emergency-to-outpatient continuity solution that ingests ED documentation, imaging, and clinical data from the EHR, surfaces imaging-driven findings and referral signals needing follow-up, and provides structured transition plans with proactive outreach to reduce avoidable ED revisits.

11Enterprise Analytics & Insights
CategoryAnalytics Solution
Description

Healthcare analytics platform that converts structured workflow activity into executive-ready dashboards covering quality and clinical performance (time-to-diagnosis, time-to-treatment, referral completion, screening adherence), operational performance (navigator capacity, workload distribution, cross-site variation), and strategic growth and financial impact.

12Closed-Loop Patient Management
CategoryCore Platform
Description

Enterprise lifecycle patient management infrastructure that identifies patients from clinical signals and diagnostic findings, connects them to accountable care teams through structured workflows and defined ownership, and manages follow-through to completion with risk-tiered prioritization, automated task creation, escalation logic, and measurable oversight.

13Thynk Health (Lung Cancer Screening & Incidental Findings)
CategoryAcquired Brand
Description

Lung cancer screening and incidental findings management platform acquired by Azra AI in April 2026, specializing in the critical window between an imaging finding and a confirmed diagnosis — pulmonary nodule tracking, Lung-RADS scoring, Fleischner Society adherence, and lung incidental findings workflows.

14Clinical Advisory Services
CategoryProfessional Services
Description

Human-in-the-loop professional services including Strategic Execution (six-pillar clinical implementation framework), Clinical and Non-Clinical Navigation as a Service, MDM Tumor Board Coordination as a Service, and Cancer Registry Case Finding as a Service — augmenting health system teams with embedded Azra-employed navigators and clinical excellence staff.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Tempus AI
TypeDirect peer
Description

Tempus AI is an oncology-focused AI and data platform that ingests multimodal clinical and molecular data to support precision oncology. It is directly comparable to Azra AI because both serve U.S. health systems with AI-powered oncology decisioning and both combine structured and unstructured clinical data at enterprise scale.

TypeDirect peer
Description

Flatiron Health is a Roche-owned oncology technology company focused on real-world clinical and molecular data for cancer care and research. It is directly comparable because it serves the same U.S. oncology ecosystem and processes oncology clinical data at scale for health systems and life-sciences sponsors.

TypeDirect peer
Description

ConcertAI is an oncology AI and real-world evidence company serving health systems, providers, and life-sciences companies. It is a direct peer because its AI-driven oncology decisioning and trial-enablement offerings overlap directly with Azra's oncology care coordination and clinical research modules.

TypeDirect peer
Description

Syapse operates a real-world evidence and precision-medicine platform for oncology, connecting health systems to life-sciences analytics. It is directly comparable to Azra because both target enterprise oncology workflows and serve as the bridge between community health-system data and pharmaceutical decisioning.

5Mendel
TypeDirect peer
Description

Mendel offers a clinical AI platform that structures unstructured EMR data and applies it to research and care workflows. It is comparable to Azra because both build HL7/FHIR-based AI platforms that turn clinical text into structured data for health systems and life-sciences customers.

TypeDirect peer
Description

Iodine Software provides AI-driven clinical documentation, mid-revenue cycle, and care-coordination tools to U.S. health systems. It is comparable to Azra because it overlays the EHR with AI-powered clinical workflows for large enterprise hospitals and uses a similar enterprise field-sales motion.

TypeEmerging player
Description

Abridge builds AI that converts patient-clinician conversations into structured clinical documentation and integrates with major EHRs. It is an emerging peer because, while it focuses on ambient documentation rather than oncology care coordination, it competes in the same HL7/FHIR-based AI overlay space and targets enterprise U.S. health systems.

TypeEmerging player
Description

LeanTaaS applies AI and predictive analytics to hospital operations, including infusion centers, operating rooms, and inpatient capacity. It is an emerging peer because it shares Azra's enterprise-health-system AI overlay model and sales motion, though it focuses on operational rather than clinical-care workflows.

TypeBroad incumbent
Description

Epic is the dominant U.S. EHR vendor and is expanding native AI and analytics capabilities for care management, registries, and trial enrollment. It is a broad incumbent because its installed base (where Azra's customers live) and growing AI portfolio represent both Azra's distribution channel and its most direct long-term competitive threat.

TypeBroad incumbent
Description

Health Catalyst is a healthcare analytics and data platform vendor serving large U.S. health systems. It is a broad incumbent because it competes for the same enterprise-analytics and care-coordination budget Azra targets, while operating a wider portfolio that includes non-oncology service lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Azra AI

Healthcare AI Workflow Automationazra-ai.com

Azra AI is a Nashville-based healthcare AI company that sells an enterprise platform automating oncology, radiology, cardiology, ED, and clinical research workflows for U.S. health systems, integrating with Epic and Cerner.

What Azra AI does

Azra AI is a Nashville, Tennessee-based healthcare AI company founded in 2022 that sells an enterprise platform automating clinical workflows across oncology, radiology, cardiology, emergency medicine, and clinical research. The platform is delivered through multiple modules — including oncology navigation (Journey), radiology incidental findings, high-risk screening, multi-disciplinary case review, tumor board, cancer registry abstraction, cardiology, ED discharge coordination, and enterprise analytics — and integrates with Epic and Cerner via HL7/FHIR. Underlying capabilities combine NLP for unstructured clinical text, predictive analytics, agentic AI with human-in-the-loop design, and process automation, with a reported sub-2% false positive rate on radiology incidental findings and a corpus of more than half a billion clinical reports processed annually across the deployed base. In May 2026 the company launched an Agentic AI Clinical Research Platform connecting health systems with pharma sponsors, and in April 2026 it acquired Thynk Health, adding lung cancer screening and oncology workflow capabilities and installing Daniel Weeks as COO.

The company monetizes through enterprise SaaS subscriptions, quote-based multi-year contracts with U.S. health systems, and managed clinical services that embed navigators, tumor board coordinators, and registry staff alongside the software. It has also introduced a pharma-sponsor transaction-based revenue stream via the Clinical Research Network. Customer disclosures indicate deployment at hundreds of U.S. health systems, including 5 of the top 10, but no individual customer logos or revenue concentration data are publicly disclosed. The company has raised approximately $15.9M across a 2022 seed round and a July 2025 Series 2 led by Connexa Capital with NewHealth Ventures and SJF Ventures.

Azra AI firmographics

Firmographics
Name
Azra AI
Legal name
Azra AI
Website
https://azra-ai.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
51–100 employees
Short description
Azra AI is a Nashville-based healthcare AI company that sells an enterprise platform automating oncology, radiology, cardiology, ED, and clinical research workflows for U.S. health systems, integrating with Epic and Cerner.
Ownership category
akta.pro rank

Azra AI industry classification

Industry
Product category
Healthcare AI Workflow Automation
NAICS
Software Publishers (5132), Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLACABAC
Enterprise Integration Engines & Interface Management (HL7 v2/X12/API)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Oncology workflow automation
  • Clinical AI platform
  • EHR integration software
  • Cancer screening solutions
  • Patient navigation software

Where Azra AI is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Azra AI business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise SaaS platform subscriptions: Recurring enterprise contracts with U.S. health systems for the Azra AI platform spanning oncology, radiology, cardiology, ED continuity, clinical trials and registry automation. Deployed across hundreds of hospitals including five of the top ten U.S. healthcare systems, indicating large multi-year, enterprise SaaS agreements rather than transactional or self-serve pricing.
  2. Embedded clinical professional services (Navigation, MDM/Tumor Board, Cancer Registry Case Finding, Strategic Execution): Azra-employed navigators, tumor board coordinators, registry case finders and clinical excellence teams are deployed as an extension of the customer's team, billed as managed services on top of the platform. Described as flexible capacity extension without long-term FTE commitments from the customer.
  3. Pharmaceutical / clinical research network partnerships: The Azra Clinical Research Network connects health systems to a pipeline of pharmaceutical studies, offering pharma companies a high-fidelity, "ready-to-enroll" site network. Represents a transaction- or sponsor-driven revenue stream from pharma for trial enrollment, feasibility and reporting services.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based enterprise contract for the Azra AI platform and embedded services

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Azra AI product offering

Product offering

Core offering

Azra AI provides an agentic AI clinical intelligence platform that bi-directionally integrates with leading EHRs (Epic, Cerner) via HL7/FHIR to deliver closed-loop, enterprise patient management across oncology, radiology, cardiology, emergency department, cancer registry and clinical trial workflows. The platform applies clinically trained NLP and disease-specific classification models to unstructured pathology, radiology and clinical reports to extract findings, stratify risk, and route patients into structured care pathways. It is sold as multi-year enterprise SaaS subscriptions bundled with embedded Azra-employed clinical navigators, tumor board coordinators and registry case finders.

Product overview

Azra AI is offered as a single unified enterprise platform with a suite of integrated solution modules rather than standalone products. The core is the Azra AI Enterprise Platform — a healthcare-grade agentic AI and workflow automation layer that bi-directionally integrates with leading EHRs (Epic, Cerner) via HL7/FHIR to overlay closed-loop patient management onto existing systems. The platform comprises the Closed-Loop Patient Management backbone plus named modules: Journey (Oncology Navigation), Radiology Incidental Findings (lung, breast, pancreas, liver, renal, GYN, neuro), High-Risk Screening Follow-Up, Multi-Disciplinary Case Review, Tumor Board, Cancer Registry Automation, Cardiology (Structural Heart), ED Discharge Coordination, the Agentic AI Clinical Research Platform (introduced May 2026 with the Unified Patient Intelligence Layer and Azra Clinical Research Network), and Enterprise Analytics & Insights. Thynk Health, acquired in April 2026, extends the platform with lung cancer screening and incidental findings depth. Clinical Advisory Services (Strategic Execution, Navigation as a Service, MDM Tumor Board Coordination, Cancer Registry Case Finding) provide human-in-the-loop stewardship on top of the technology. Together these modules power solutions across lung and breast cancer screening, incidental findings, multi-disciplinary meetings, oncology care coordination, clinical trial matching, ED discharge, and reporting & analytics within a single coordinated ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

  • Journey: Azra AI's oncology navigation software product that surfaces cancer patients at diagnosis, delivers risk-stratified navigator worklists, automated workflows, and real-time analytics.

Products and services

  • Azra AI Enterprise Platform Healthcare enterprise AI platform that operationalizes underutilized clinical data to optimize and orchestrate care and clinical trial pathways. Combines agentic AI, multimodal data integration and workflow automation to transform fragmented clinical data into actionable intelligence, overlaying EHRs with bidirectional HL7/FHIR integration.
  • Journey (Oncology Navigation) Oncology navigation module that surfaces high-risk patients at the moment of cancer diagnosis, prioritizes worklists by acuity and distress risk, automates distress screenings, consult scheduling, and follow-up documentation, and feeds data back to the EHR.
  • Agentic AI Clinical Research Platform Clinical research platform built on Azra AI's real-time care orchestration engine that introduces a Unified Patient Intelligence Layer, Conversational UI for feasibility, autonomous agentic pre-screening and enrollment, proactive trajectory tracking, the Azra Clinical Research Network, automated portfolio reporting, and full traceability to source EMR data.
  • Radiology Incidental Findings AI-powered imaging solution that ingests HL7/FHIR radiology reports, uses NLP to extract incidental findings (location, size, density, margins, nodule count) with under 2% false positives, applies risk stratification, and routes patients into surveillance or treatment pathways using guideline-aligned models (Lung-RADS, Fleischner, BI-RADS, LI-RADS, Bosniak, ACG/AGA).
  • High-Risk Screening Follow-Up Screening follow-up and compliance solution covering Lung-RADS result tracking, BI-RADS surveillance interval management, and colorectal polyp surveillance that monitors every screening result, triggers guideline-matched follow-up activities, populates navigator worklists, and writes back to discrete EHR fields.
  • Multi-Disciplinary Case Review Module that continuously monitors patient populations, flags individuals with high-risk findings (lung nodules, suspicious masses, incidental findings), assembles customizable meeting agendas, captures recommendations during case conferences, assigns action items with due dates and ownership, and surfaces overdue actions via automated alerts.
  • Tumor Board Tumor board solution that proactively identifies newly diagnosed cancer patients, prepares customized case agendas with radiology, pathology and clinical history, captures recommendations, assigns navigation tasks, and supports Commission on Cancer (CoC) Standard 2.5 accreditation through structured data capture and automated reporting.
  • Cancer Registry Automation Automated cancer registry case-finding solution that surfaces newly diagnosed cases by disease site in real time from pathology and radiology reports, integrates with the registry database, supports human-in-the-loop validation, and provides reporting for CoC, NAPBC, NAPRC, and NAACCR accreditation requirements.
  • Cardiology (Structural Heart) AI-powered cardiology module for detection, acuity stratification, and closed-loop care coordination for structural heart disease (aortic and mitral stenosis). Surfaces findings from echocardiography, CT, and MRI, classifies by severity (mild/moderate/severe), routes to accountable care teams, and is expanding to automated population of STS/TVT registry fields.
  • ED Discharge Coordination Emergency-to-outpatient continuity solution that ingests ED documentation, imaging, and clinical data from the EHR, surfaces imaging-driven findings and referral signals needing follow-up, and provides structured transition plans with proactive outreach to reduce avoidable ED revisits.
  • Enterprise Analytics & Insights Healthcare analytics platform that converts structured workflow activity into executive-ready dashboards covering quality and clinical performance (time-to-diagnosis, time-to-treatment, referral completion, screening adherence), operational performance (navigator capacity, workload distribution, cross-site variation), and strategic growth and financial impact.
  • Closed-Loop Patient Management Enterprise lifecycle patient management infrastructure that identifies patients from clinical signals and diagnostic findings, connects them to accountable care teams through structured workflows and defined ownership, and manages follow-through to completion with risk-tiered prioritization, automated task creation, escalation logic, and measurable oversight.
  • Thynk Health (Lung Cancer Screening & Incidental Findings) Lung cancer screening and incidental findings management platform acquired by Azra AI in April 2026, specializing in the critical window between an imaging finding and a confirmed diagnosis — pulmonary nodule tracking, Lung-RADS scoring, Fleischner Society adherence, and lung incidental findings workflows.
  • Clinical Advisory Services Human-in-the-loop professional services including Strategic Execution (six-pillar clinical implementation framework), Clinical and Non-Clinical Navigation as a Service, MDM Tumor Board Coordination as a Service, and Cancer Registry Case Finding as a Service — augmenting health system teams with embedded Azra-employed navigators and clinical excellence staff.

Quantifiable outcome

  • 3× faster to treatment vs. standard unmanaged follow-up
  • +7 more outcomes

Companies that use Azra AI

Customer profile

Segments3 records

Ideal customer profiles3 records

Azra AI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability9 records

Feature7 records

Azra AI partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Azra AI competitors and assessment

Company assessment

Direct peers

  • Tempus AI: Tempus AI is an oncology-focused AI and data platform that ingests multimodal clinical and molecular data to support precision oncology. It is directly comparable to Azra AI because both serve U.S. health systems with AI-powered oncology decisioning and both combine structured and unstructured clinical data at enterprise scale.
  • Flatiron Health: Flatiron Health is a Roche-owned oncology technology company focused on real-world clinical and molecular data for cancer care and research. It is directly comparable because it serves the same U.S. oncology ecosystem and processes oncology clinical data at scale for health systems and life-sciences sponsors.
  • ConcertAI: ConcertAI is an oncology AI and real-world evidence company serving health systems, providers, and life-sciences companies. It is a direct peer because its AI-driven oncology decisioning and trial-enablement offerings overlap directly with Azra's oncology care coordination and clinical research modules.
  • Syapse: Syapse operates a real-world evidence and precision-medicine platform for oncology, connecting health systems to life-sciences analytics. It is directly comparable to Azra because both target enterprise oncology workflows and serve as the bridge between community health-system data and pharmaceutical decisioning.
  • Mendel: Mendel offers a clinical AI platform that structures unstructured EMR data and applies it to research and care workflows. It is comparable to Azra because both build HL7/FHIR-based AI platforms that turn clinical text into structured data for health systems and life-sciences customers.
  • Iodine Software: Iodine Software provides AI-driven clinical documentation, mid-revenue cycle, and care-coordination tools to U.S. health systems. It is comparable to Azra because it overlays the EHR with AI-powered clinical workflows for large enterprise hospitals and uses a similar enterprise field-sales motion.

Emerging players

  • Abridge: Abridge builds AI that converts patient-clinician conversations into structured clinical documentation and integrates with major EHRs. It is an emerging peer because, while it focuses on ambient documentation rather than oncology care coordination, it competes in the same HL7/FHIR-based AI overlay space and targets enterprise U.S. health systems.
  • LeanTaaS: LeanTaaS applies AI and predictive analytics to hospital operations, including infusion centers, operating rooms, and inpatient capacity. It is an emerging peer because it shares Azra's enterprise-health-system AI overlay model and sales motion, though it focuses on operational rather than clinical-care workflows.

Broad incumbents

  • Epic Systems: Epic is the dominant U.S. EHR vendor and is expanding native AI and analytics capabilities for care management, registries, and trial enrollment. It is a broad incumbent because its installed base (where Azra's customers live) and growing AI portfolio represent both Azra's distribution channel and its most direct long-term competitive threat.
  • Health Catalyst: Health Catalyst is a healthcare analytics and data platform vendor serving large U.S. health systems. It is a broad incumbent because it competes for the same enterprise-analytics and care-coordination budget Azra targets, while operating a wider portfolio that includes non-oncology service lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Azra AI social profiles

Digital presence

Azra AI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Azra AI leadership team

Management profile

Number of profiles

Profiles13 records

Azra AI subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Azra AI funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Azra AI M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Azra AI

What does Azra AI do?

Azra AI provides an agentic AI clinical intelligence platform that bi-directionally integrates with leading EHRs (Epic, Cerner) via HL7/FHIR to deliver closed-loop, enterprise patient management across oncology, radiology, cardiology, emergency department, cancer registry and clinical trial workflows. The platform applies clinically trained NLP and disease-specific classification models to unstructured pathology, radiology and clinical reports to extract findings, stratify risk, and route patients into structured care pathways. It is sold as multi-year enterprise SaaS subscriptions bundled with embedded Azra-employed clinical navigators, tumor board coordinators and registry case finders.

Is Azra AI a public or private company?

Azra AI is a private company. It is classified as venture growth investor backed and is currently operating.

When was Azra AI founded?

Azra AI was founded in 2022. It employs 51 to 100 people.

Where is Azra AI based?

Azra AI is headquartered in Nashville, United States, in the North America region.

How does Azra AI make money?

Three revenue lines are on record. Enterprise SaaS platform subscriptions are the primary driver. The others are embedded clinical professional services (Navigation, MDM/Tumor Board, Cancer Registry Case Finding, Strategic Execution) and pharmaceutical / clinical research network partnerships.

Who are Azra AI's main competitors?

Direct peers on record are Tempus AI, Flatiron Health, ConcertAI, Syapse, Mendel and Iodine Software. Emerging players are Abridge and LeanTaaS. Broad incumbents are Epic Systems and Health Catalyst.

Does Azra AI have an API?

No public API is recorded for Azra AI.

What industry is Azra AI in?

Azra AI's product category is Healthcare AI Workflow Automation. Its primary akta.pro industry code is HLACABAC, Enterprise Integration Engines & Interface Management (HL7 v2/X12/API), with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Azra AI Acquires Blackford Analysis To Connect Imaging AI With Patient CareAzra AI completed its acquisition of Blackford Analysis, combining Blackford's vendor-neutral imaging AI orchestration platform with Azra's patient management technology. The combined platform supports over 130 AI applications from 45 vendors and aims to reduce cases where imaging findings are documented but not followed up. John Marshall will lead the combined companies.PR NewswireAzra AI Acquires Blackford Analysis to Close the Most Dangerous Gap in Healthcare: What Happens After the ScanAzra AI completed its acquisition of Blackford Analysis, adding imaging AI orchestration to its end-to-end patient care platform. The deal, from parent company Sopris Capital, integrates over 130 AI applications from 45 vendors, aiming to close care gaps where imaging findings fail to lead to treatment. CEO John Marshall will lead the combined company.citybizSopris Capital Acquires Blackford Analysis from Bayer, Plans Integration with Azra AISopris Capital completed its acquisition of Blackford Analysis from Bayer, adding an AI orchestration platform for medical imaging. The deal is not disclosed, and Sopris plans to combine Blackford with Azra AI within days or weeks. Blackford will remain a separate legal entity, and the integration aims to link imaging analysis with patient care coordination.Medical Device Network4DMedical and Azra AI join forces to advance lung care pathways4DMedical and Azra AI have established a strategic reseller partnership to streamline lung care pathways for health systems. Under the agreement, 4DMedical will resell Azra AI's patient identification platform while integrating its own quantitative imaging solutions to provide objective data for clinical decision-making.PR NewswireAzra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health SystemsAzra AI and 4DMedical have announced a strategic OEM and reseller partnership to integrate their respective technologies for lung health intelligence. Under the agreement, 4DMedical will resell Azra AI's patient identification platform to its health system customers, combining it with 4DMedical's quantitative imaging analytics to improve care coordination. The joint solution aims to help health systems identify patients with various pulmonary conditions earlier and manage their treatment pathways more effectively.YahooAzra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health SystemsAzra AI and 4DMedical announced a strategic OEM and reseller partnership to integrate Azra AI's patient identification platform with 4DMedical's quantitative lung imaging analytics. This collaboration enables health systems to automatically detect, route, and manage patients with various pulmonary conditions across their care journey.YahooAzra AI and Blackford partner to connect imaging AI with care coordinationAzra AI and Blackford have formed a partnership to integrate their healthcare AI platforms, combining Blackford's enterprise imaging AI platform (featuring over 130 clinically validated AI applications) with Azra AI's care navigation and incidental findings management system. The collaboration aims to address the common problem of critical imaging findings not being acted upon due to inadequate follow-up infrastructure, ensuring patients are guided through appropriate treatment pathways. Azra AI CEO John Marshall stated the mission is to connect every identified patient to the right care at the right time, while Blackford's managing director James Holroyd noted the partnership extends AI capabilities beyond detection into patient treatment.Medical Device NetworkAzra AI and Blackford partner to connect imaging AI with care coordinationAzra AI and Blackford have formed a strategic partnership combining Blackford's enterprise AI imaging platform with over 130 AI applications and Azra AI's care navigation and incidental findings management system. The collaboration aims to address the common problem of critical imaging findings not being acted upon due to lack of follow-up infrastructure, connecting patients identified through AI detection to appropriate treatment pathways. Azra AI's platform is currently deployed across numerous US hospitals and health systems, while Blackford provides AI solutions to hospitals, radiology groups, and imaging centers.YahooAzra AI and Blackford partner to connect imaging AI with care coordinationAzra AI and Blackford have formed a partnership to integrate Blackford's AI imaging platform with Azra AI's care navigation system, aiming to ensure patients identified with critical findings receive timely follow-up care. The collaboration connects Blackford’s portfolio of over 130 AI imaging applications with Azra AI’s patient management capabilities to address gaps in post-detection infrastructure within health systems.AijournAzra AI and Blackford Announce Strategic Partnership to Close the Gap Between Imaging AI and Enterprise Care CoordinationAzra AI and Blackford announced a strategic partnership on August 5, 2026 to advance the detection-to-treatment pathway for patients with complex and time-sensitive diagnoses. The partnership combines Blackford's enterprise AI platform, which integrates over 130 clinically validated AI imaging applications across radiology workflows, with Azra AI's care coordination and navigation capabilities to ensure identified patients are promptly reached and managed through appropriate care pathways. The collaboration aims to address a persistent challenge in health systems where imaging AI findings risk falling through the cracks without coordinated follow-up infrastructure.